Clinically relevant doses of the tumour vascular focusing on agent, combretastatin A-4-phosphate (CA-4-P), have been investigated in the rat P22…
Clinically relevant doses of the tumour vascular focusing on agent, combretastatin A-4-phosphate (CA-4-P), have been investigated in the rat P22…